-

Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle

SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that their previously mentioned Advance Safety Needle System has entered full scale production on their automated machine. The Advance needle was tested in 2021, has been used in Kurin accounts since last year and is now widely available.

“We are pleased with the transition to automated manufacturing of the Advance Safety Needle, as market demand for alternative needles has been strong,” said Bob Rogers, CEO of Kurin, Inc. “Needle manufacturers have created significant stress in the supply chain with widescale backorders and unprecedented price increases. With our Advance needle, we can better control product availability for the growing Kurin customer base, as well as entertain inquiries from strategic partners looking for their own push-button needle. In addition, we are pleased that Advance shows improved performance characteristics compared to traditional, retraction-oriented products.“

Kurin’s revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening infections caused by C. diff.

About Kurin, Inc.

Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.

Contacts

Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com

Kurin, Inc.


Release Summary
Kurin, Inc. announced that their Advance Safety Needle System™ has entered full scale automated production and is now widely available.
Release Versions

Contacts

Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com

More News From Kurin, Inc.

Kurin and Crouse Hospital: A Transformative Partnership in Reducing Contaminated Blood Cultures

SAN DIEGO--(BUSINESS WIRE)--The synergy between Kurin's technology and Crouse Hospital's dedication to excellence sets a new standard for managing contaminated blood cultures....

Kurin Works with The Ohio State University Wexner Medical Center on Patient Safety and Increased Access to High Quality Healthcare

SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc. and The Ohio State University Wexner Medical Center are working together to reduce contaminated blood cultures....

Final Judgment Entered in Kurin’s Favor over Magnolia Medical

SAN DIEGO--(BUSINESS WIRE)--U.S. District Court for the District of Delaware entered Final Judgment that Kurin Inc. does not infringe Magnolia Medical, Inc.’s patent...
Back to Newsroom